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Osteoblast differentiationanscription factor TWIST1 is associated with Saethre–Chotzen Syndrome and is
manifested by craniosynostosis, which is the premature closure of the calvaria sutures. Previously, we found
that Twist1 forms functional homodimers and heterodimers that have opposing activities. Our data
supported a model that within the calvaria sutures Twist1 homodimers (T/T) reside in the osteogenic fronts
while Twist1/E protein heterodimers (T/E) are in the mid-sutures. Twist1 haploinsufﬁciency alters the
balance between these dimers, favoring an increase in homodimer formation throughout the sutures. The
data we present here further supports this model and extends it to integrate the Twist1 dimers with the
pathways that are known to regulate cranial suture patency. This data provides the ﬁrst evidence of a
functional link between Twist1 and the FGF pathway, and indicates that differential regulation of FGF
signaling by T/T and T/E dimers plays a central role in governing cranial suture patency. Furthermore, we
show that inhibition of FGF signaling prevents craniosynostosis in Twist1+/− mice, demonstrating that
inhibition of a signaling pathway that is not part of the initiating mutation can prevent suture fusion in a
relevant genetic model of craniosynostosis.
© 2008 Elsevier Inc. All rights reserved.Introduction
The ﬂat bones of the skull remain separated by openings termed
sutures that function as the growth centers of the bones, allowing
growth of the skull during fetal and postnatal development. At the
edges of these bones are the osteogenic fronts that contain highly
proliferative cells expressing osteogenic markers such as Runx2 and
alkaline phosphatase (Cohen, 2000; Opperman, 2000). The mid-suture
region is composed of mesenchymal precursor cells. In the human, the
sutures gradually close from infancy to young adult. The premature
closure of sutures, termed craniosynostosis, is a fairly common
disorder, occurring in 1 in 2500 births. Non-syndromic craniosynos-
tosis is most common, however approximately 20% of all cases are
associated with mutations in the gene TWIST1 or one of the ﬁbroblast
growth factor receptor (FGFR) genes (Cunningham et al., 2007; Lenton
et al., 2005; Rice, 2005). There is a complex relationship between
Twist1 and FGF signaling which is not completely understood.icine, Maine Medical Center
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l rights reserved.Increases in Twist1 expression and FGF signaling have both been
associated with an inhibition of osteoblast differentiation in vitro, yet
craniosynostosis occurs due to activating mutations of the FGFR genes
and haploinsufﬁciency of TWIST1 (Cunningham et al., 2007; Lenton et
al., 2005; Rice, 2005). Eighty percent of patientswith Saethre–Chotzen
Syndrome (SCS), which is one of the most common autosomal
dominant disorders of craniosynostosis, have mutations in TWIST1,
however mutations in FGFR2 and FGFR3 have also been reported in
some patients that have phenotypes consistent with SCS, exemplify-
ing this relationship and further indicating that haploinsufﬁciency of
TWIST1 gives a similar phenotype as activation of FGFR signaling
(Chun et al., 2002; el Ghouzzi et al., 1997; Howard et al., 1997;
Paznekas et al., 1998). Receptor tyrosine kinase signaling by FGF, IGF1,
and HGF induces the expression of Twist1 (Dupont et al., 2001; Fang et
al., 2001; Isaac et al., 2000; Leshem et al., 2000; Rice et al., 2000),
while Twist can affect the expression of FGF receptor genes. In Dro-
sophila and Caenorhabditis elegans, Twist induces the expression of the
FGFR homolog DFR1 and egl-15, respectively (Castanon and Baylies,
2002); however, the relationship between Twist1 and FGFR in
vertebrates has been less clear. In the cranial sutures, FGFR2 ex-
pression is normally only detected in the osteogenic fronts but it
extends into the mid-suture of Twist1+/− mice, suggesting that Twist1
may normally inhibit FGFR2 expression (Connerney et al., 2006; Rice
Fig. 1. Model. (A) Drawing showing parts of a suture going from a more differentiated bone to a less differentiated mid-suture mesenchyme. The model shows T/T dimers up-
regulating FGFR2 expression resulting in increased FGF signaling toward the middle of the suture. FGF signaling inhibits the expression of the BMP antagonist noggin, resulting in
increased BMP signaling which up-regulates Id1 expression, further enhancing T/T homodimer formation. On the other hand, T/E dimers inhibit FGFR2 expression, as well as BMP
signaling through binding to Smad proteins. T/E dimers also up-regulate TSP1 expression, which activates latent TGFβ. This could have differing outcomes dependent onwhich TGFβ
isoform is present. (B) The ratio of T/T toT/E determines the functional output of Twist1 expression, and this is determined by the relative expression of Twist1 and Id1 proteins.When
Id1 levels are greater that Twist1 this balance is shifted toward T/T formation resulting in up-regulation of FGFR2 leading to craniosynostosis. When Twist1 levels are higher than Id1
the balance is toward an increase in T/E formation, inhibiting FGFR2 expression and resulting in patent sutures.
324 J. Connerney et al. / Developmental Biology 318 (2008) 323–334et al., 2000). However, calvaria cells isolated from a SCS patient with a
mutation in TWIST1 had decreased FGFR2 levels, whichwere increased
when Twist1 was ectopically expressed (Guenou et al., 2005).
Therefore, the relationship between Twist1 and FGFR2may be context
dependent. Consistent with this, we recently found that Twist1 forms
different dimer complexes that have opposing effects on FGFR2
expression (Connerney et al., 2006).
Twist1 is a basic-Helix–Loop–Helix (bHLH) transcription factor
that plays both positive and negative roles in the regulation of early
morphogenesis and differentiation of mesenchymal tissues (O'Rourke
and Tam, 2002). We found that, unlike most other bHLH proteins,
Twist1 can form functional homodimers (T/T) as well as heterodimers
with ubiquitously expressed bHLH E proteins (T/E). These dimers
have distinct activities and regulate the expression of different sets of
genes. The ratio between these dimers is determined by the relative
levels of Twist1 and the HLH Id proteins (Connerney et al., 2006). Id
proteins preferentially dimerize with E proteins and disrupt func-
tional Class I/II bHLH heterodimers from forming (Massari and Murre,
2000). We found that Twist1 formed T/E dimers in the absence of
Id, and formed T/T dimers when Id levels were increased (Connerney
et al., 2006). Consistent with this, we found that in the sutures, genes
that are regulated by T/T dimers, such as FGFR2 and periostin, are
expressed in the osteogenic fronts where Twist1 and Id1 are co-
expressed, while T/E-regulated genes, such as thrombospondin 1
(TSP-1), are expressed in the mid-sutures where only Twist1 is ex-
pressed. In the sutures of Twist1+/− mice, the ratio between these
dimers is altered, favoring an increase in homodimers and an ex-
pansion into the mid-suture of the expression of T/T-regulated genes,and a complete absence of T/E-regulated genes. Furthermore, we
were able to inhibit craniosynostosis in Twist1+/− mice by modulating
the balance between these dimers toward T/E formation, by either
increasing the expression of E2A E12 or by decreasing Id1 expression
(Connerney et al., 2006).
Here we propose a model that integrates Twist1 dimer form-
ation with the signaling pathways known to regulate cranial suture
patency (Fig. 1A). Our model predicts that the decrease in Twist1
expression due to Twist1 haploinsufﬁciency results in a higher T/T
to T/E ratio extending beyond the osteogenic fronts due to Id1
levels out-competing Twist1 for dimerization with E proteins. The
increase in T/T dimers expands the expression of FGFR2, resulting
in increased FGF signaling. T/E dimers have recently been shown
to inhibit BMP signaling (Hayashi et al., 2007), which is predomi-
nantly active in the osteogenic fronts (Warren et al., 2003), and
therefore the decrease in T/E dimers in Twist1+/− sutures, would
allow for an expansion of BMP signaling as well. BMP signaling
induces Id expression (Rice et al., 2000), which would further pro-
mote T/T formation. This positive feedback loop then causes the
sutures to close prematurely, resulting in craniosynostosis. Our data
support this hypothesis and illustrate that the sutures of Twist1+/−
mice have increased FGF and BMP signaling, and that inhibition of
FGF signaling prevents craniosynostosis in Twist1+/− mice. Further-
more, enhanced T/T expression on a wild type background leads
to a similar suture closure phenotype as Twist1+/− mice, indicating
that T/T dimers play an active role in promoting craniosynostosis,
and that the balance between the Twist1 dimers dictates suture
patency.
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Transgenic mice
Twist1+/− mice were obtained from the Jackson Laboratory, Bar Harbor, ME. Cre-
responsive transgenes CC–TT, CC–TE, and CG–Spry1were constructed bymodiﬁcation of
the CAG–CAT–Z construct, which contains a CMV enhancer-chicken β-actin gene (CAG)
promoter-loxP1–chloramphenicol acetyltransferase (CAT) gene-loxP1–LacZ gene (Araki
et al.,1995). The CC–TTand CC–TE constructs replaced the LacZ genewith a cassette from
pIREShrGFP (Stratagene, La Jolla, CA) constructs containing the myc-tagged TT and TE
tethered dimers (Connerney et al., 2006) upstream of an IRES-hrGFP. The CC–TTand CC–
TE constructs constitutively express CAT, and Cre recombinase-induced expression of
either TT or TE and hrGFP, although the hrGFP expression is weak. The CG–Spry1
construct was generated by replacing the CAT gene with the GFP gene, and replacing
LacZ with a myc/his-tagged mouse Spry1 open reading frame, generated by PCR using
gene speciﬁc primers. The CG–Spry1 construct has constitutive GFP expression, and Cre
recombinase-induced activation of Spry1 expression with concomitant loss of the GFP
marker (Yang, et al., in preparation). Transgene activation by Cre recombinase was
validated in Cre8 cells in vitro by immunoblotting using anti-myc antibodies (Upstate
Biotech, Temecula, CA). The puriﬁed linearized construct was introduced by pronuclear
injection on the FVB background. Resultant mice were screened for CAT or GFP
expression, respectively, and founder lines validated by genotyping using CAT or GFP-
speciﬁc primers. CAT primers: 5′-TGTGGTATGGCTGATTATGATCTC (Forward) and 3′-
GCAGTGGTGGAATGCCTTTA-3′ (Reverse), which amplify a 460bp fragment; GFP
primers: 5′-CTCGAGCCACCATGAGTAAAGGAGAAGAAC-3′ (Forward) and 5′-CTTCAC-
TATTTGTAGAGTTCATCCATGC-3′ (Reverse), which amplify a 733bp fragment.
We crossed these transgenic mice with CAG-estrogen receptor/Cre recombinase
(CreERT2) mice (Hayashi and McMahon, 2002). Activation of CreERT2 was achieved by
injection of tamoxifen (10mg/ml corn oil). To harvest embryos for calvarial explants, CC–TT
andCC–TE femaleswere crossedwithCAG–CreERT2males. Femaleswere injectedwith 8mg/
40g body weight tamoxifen at embryonic day 15.5 (E15.5) and embryos were harvested at
E16.5. To activate transgenes after birth, 3-day-oldpupswere injected subcutaneouslyabove
the cranial sutures with 8μg/g weight and the mice were sacriﬁced at 5 weeks.
Immunohistochemistry
Skulls from newborn mice (P1) were dissected in ice-cold PBS and transferred
immediately to cold 8% paraformaldehyde as in (Corson et al., 2003). Heads were de-
skinned and dissected free from the underlying brain. Samples were embedded in parafﬁn
and serial 5μm sections were processed for immunohistochemistry using the Vectastain
Elite ABCKit (Vector Laboratories, Burlingame,CA). Theantibodies used in this processwere
anti-phospho-p44 (Cell Signaling Technology, Danvers, MA), anti-Bek C-17 and anti-Id1 sc-
734 (Santa CruzBiotechnology, Santa Cruz, CA), and anti-phospho-Smad1/5/8 (LeClair et al.,
2007). Unbaked sections were stained for alkaline phosphatase with BM Purple.
In situ hybridization analysis
Skulls from newborn mice (P1) were ﬁxed in 4% paraformaldehyde, cryosectioned
and analyzed by in situ hybridization as in (Yoshida et al., 2005). In situ hybridization
probes were against erm (gift from B. Hogan, Duke University), and noggin. The noggin
probe was generated by PCR using the following primers: CGAGGATCCATG-
GAGCGCTGCCCCAGC, and CCGCTCGAGCTAGCAGGAACACTTACAC.
Western blot analysis
Individual frontal, coronal, and sagittal sutures were dissected from the skulls of
two P1 pups and were pooled and homogenized in passive lysis buffer (Promega)
containing Complete Mini protease inhibitor cocktail (Roche Applied Science,
Indianapolis, IN) using an Autodisruptor 24 (Autogen, Holliston, MA) following the
recommended protocol from the manufacturer. Western blot analysis was performed as
previously described (Leshem et al., 2000), using anti-phospho-Erk1/2 (Cell Signaling
Technology, Danvers, MA) and anti-β-actin (Sigma-Aldrich, St. Louis, MO). The gels
were scanned and quantiﬁed using ImageQuant 5.2 program (GE Healthcare, Piscat-
away, NJ), and fold induction between wild type and Twist1+/− sutures was determined
after normalizing each band to the level of β-actin for that sample.
Preparation of calvaria explants
Female pregnant mice were given intra-peritoneal injections of tamoxifen at E15.5
and embryos were harvested at E16.5 for explant culture. Calvarias were prepared as
previously described (Connerney et al., 2006). Brieﬂy, whole calvaria were de-skinned
and sectioned horizontally below the nose. The calvaria explants, containing the brain
and dura mater, were then placed on Falcon cell culture inserts (PET pore size 0.4μm) in
12-well dishes containing DMEM, 10mg/ml L-ascorbic acid, 500mM β-glycerolpho-
sphate,10% FBS,1% penicillin–streptomycin. Explants were incubated in a CO2 incubator
at 37°C with media changes daily.
Heparin-acrylic beads (Sigma-Aldrich, St. Louis, MO) were prepared as described
(Rice et al., 2000). Brieﬂy, beads were incubated in 25μg/ml of recombinant FGF2
protein or 25μg/ml bovine serum albumin (BSA) at 37°C for 1h and then washed with
growth media. Beads were placed either on the osteogenic fronts or in the mid-suture
mesenchyme and the calvarial explants were cultured for 5 or 7 days as indicated,changing media daily. After culture, calvaria were ﬁxed and subjected to alcian blue and
alizarin red staining to analyze the extent of suture closure.
Results
Increased FGF signaling in the sutures of Twist1+/− mice
Although FGFR2 expression is expanded in the sutures of Twist1+/−
mice (Connerney et al., 2006; Rice et al., 2000), it is unclear if this plays a
functional role in promoting craniosynostosis in these mice. Therefore,
we investigated if this expanded FGFR2 expression resulted in increased
FGF signaling and/or responsiveness within the sutures. Similar to
FGFR2 gene expression (Connerney et al., 2006), FGFR2 protein was
detected throughout the sagittal sutures of Twist1+/− mice, while its
expressionwas primarily restricted to the osteogenic fronts inwild type
mice (Fig. 2A). A similar enhancement of FGFR2 expression was also
observed in the coronal sutures. To determine the extent of FGF
activation in the sutures, we used an antibody speciﬁc for the activated
forms of Erk1/2. As can be seen in a serial section, activation of Erk1/2
correlated very closely with FGFR2 expression. Phospho-Erk1/2 was
restricted to the osteogenic fronts of wild type mice, and was expanded
to the mid-suture of Twist1+/− mice, which was particularly evident in
the coronal sutures (Fig. 2A), suggesting that there is enhanced FGF
signaling in the sutures of thesemice.Westernblot analysis of individual
sutures fromwild type and Twist1+/− mice also indicated that there was
an increase in activated Erk1/2 in the Twist1+/− sutures (Fig. 2B). Consis-
tent with the immunostaining, the most pronounced increase in Erk1/2
activation was seen in the coronal sutures, which are the sutures that
normally fuse due to Twist1 haploinsufﬁciency. Interestingly, therewere
signiﬁcant levels of activated Erk1/2 in the frontal sutures of wild type
mice, which is the only cranial suture that normally fuses. This is
consistent with FGF activity being associated with fusing sutures
(Warren et al., 2003). Because Erk1/2 activity is not speciﬁc to FGF
signaling, we alsomonitored the expression of erm, whose expression is
primarily associated with FGF8 expression, but is also found in some
other FGF signaling centers (Brent and Tabin, 2004; Firnberg and
Neubuser, 2002; Lunn et al., 2007; Raible and Brand, 2001). Consistent
with its regulation by FGF, erm expression was restricted to the
osteogenic fronts in wild type sagittal and coronal sutures, and its
expression increased throughout the sutures in Twist1+/− mice (Fig. 2B).
Increased BMP signaling in Twist1+/− sutures
Ourmodel predicts that therewould be expanded BMP signaling in
the sutures of Twist1+/− mice as well as increased FGF signaling. T/E
dimers inhibit BMP signaling (Hayashi et al., 2007), and therefore we
predicted that Twist1+/− sutures would have increased BMP signaling
due to a decrease in T/E dimers. The BMP inhibitor noggin is also
expressed in the suture mesenchyme, and its expression is repressed
by FGF signaling (Warren et al., 2003). Therefore, an increase in FGF
signaling in the Twist1+/− sutures would be expected to decrease nog-
gin expression. The loss of T/E dimers and noggin expressionwould be
predicted to result in an expansion of BMP signaling in these mice. To
test this hypothesis, we examined the expression of noggin and the
activation of the BMP pathway in the sutures of wild type and Twist1+/−
mice. We analyzed noggin expression by in situ hybridization and
found it to be expressed at fairly low levels throughout the suture
mesenchyme of wild type mice and slightly decreased in Twist1+/−
mice (Fig. 2C). The expression of noggin in the sutures was originally
determined using the expression ofβ-galactosidase from the LacZ gene
that was knocked into the noggin locus, and therefore the levels of
endogenous noggin were not determined (Warren et al., 2003). Our
data suggest that noggin is not expressed at high levels in the sutures.
BMPs signal through the Smadproteins. Ligand activation of the BMP
receptors results in the phosphorylation of Smads 1, 5, and8,which then
complex with Smad 4 to transport to the nucleus to regulate gene
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Fig. 3. Twist1+/− sutures aremore responsive to FGF. (A) E16.5 calvarias stained with alcian blue and alizarin red. Note that wild type and Twist1+/− calvaria are phenotypically the same
at this stage. The drawing in the middle shows the location of beads (red dots) that were placed on the osteogenic fronts (OF) or on the mid-sutures (MS). (B) BSA or FGF2-soaked
beads were placed on the osteogenic fronts or mid-sutures of wild type and Twist1+/− E16.5 calvaria, and the explants were cultured for 7 days. FGF2 beads placed on the osteogenic
fronts induced suture closure in both wild type and Twist1+/− explants, while only the Twist1+/− sutures closed when FGF2 beads were placed on the mid-sutures. (C) Table showing
the results of beads placed either on osteogenic fronts or mid-suture of calvaria explants of wild type versus Twist1+/−mice. Suture closurewas deﬁned as when the two parietal bones
came in contact.
327J. Connerney et al. / Developmental Biology 318 (2008) 323–334transcription. One of the genes that is regulated by BMP signaling is Id1
(Rice et al., 2000), and therefore we monitored BMP activity using an
antibody speciﬁc for phospho-Smad 1/5/8, and by monitoring Id1
expression.We found that phospho-Smad1/5/8wasprimarily restricted
to the osteogenic fronts in wild type mice, and increased and expanded
to the mid-suture of Twist1+/− sutures as predicted (Fig. 2A). Id1 ex-
pression correlated closely with where Smad1/5/8 was activated. Id1
was expressed in the osteogenic fronts of wild type mice and expanded
throughout the sutures in Twist1+/− mice. As with the effect on FGF
signaling, the coronal sutures showed a more signiﬁcant increase than
the sagittal sutures. Therefore, Twist1 haploinsufﬁciency results in
expanded activation of both the FGF and BMP signaling pathways,
leading to enhanced Id1 expression, as our model predicts.Fig. 2. Increased FGF and BMP signaling in the sutures of Twist1+/−mice. (A) Immunohistoche
and coronal sutures of wild type and Twist1+/− P1 mice. Arrow heads indicate the osteogenic
data is shown. Note the extended staining for all of these throughout the sutures of Twist1+/−
Western blot analysis of phopho-Erk1/2 in wild type and Twist1+/− sutures. Protein extracts
mice were pooled and analyzed by western blot analysis for phopho-Erk1/2 and β-actin. The
and Twist1+/−mice when corrected for β-actin expression. (C) In situ hybridization analysis of
P1 mice. The red dotted lines outline the calvaria bones.Twist1+/− sutures are more responsive to FGF2 than wild type controls
The restriction of FGFR2 expression to the osteogenic fronts of wild
type mice correlates with a differential response of these cells to FGF
compared with the cells of the mid-suture. FGF2-soaked beads induce
suture closure when placed on the osteogenic fronts of explanted wild
type E16.5 calvaria, but not when placed in the middle of the sagittal
suture (Kim et al., 1998). To determine if the expanded FGFR2
expression in Twist1+/− mice altered the response of the mid-suture
cells to FGF2, we used the calvaria explant assay. At E16.5, the calvaria
of wild type and Twist1+/− mice are phenotypically very similar (Fig.
3A).Whole calvaria fromE16.5micewere explanted, and beads soaked
in 25μg/ml BSA or FGF2 were placed on either the osteogenic fronts ormistry for FGFR2, phospho-ERK1/2, phospho-smad1/5/8, and Id1 proteins in the sagittal
fronts. Analysis of at least 3 mice of each genotype was performed, and representative
mice, while they are primarily restricted to the osteogenic fronts in wild type mice. (B)
from dissected frontal, coronal, and sagittal sutures from two P1 wild type or Twist1+/−
bar graph shows the fold change in phospho-Erk1/2 for each suture between wild type
erm and noggin expression in the sagittal and coronal sutures of wild type and Twist1+/−
Fig. 4. FGF signaling is required for craniosynostosis in Twist1+/− mice. (A) Efﬁcient tamoxifen-induced cre recombination in the sutures. The sutures of 3-day-old pups from R26R
reporter mice crossed with CAG–CreERTmice were injected with tamoxifen to induce expression of β-galactosidase from the R26R locus. The mice were then harvested at P7 and the
coronal sutures were analyzed for β-galactosidase expression. Note expression throughout the coronal suture. (B) Expression of Spry1 in the sutures of Twist1+/− mice prevents
craniosynostosis. Spry1 expression was induced from the CG–Spry1 transgene in CG–Spry1;CAG–CreERT2mice on a wild type or Twist1+/− background by injection of tamoxifen into
the sutures of P3 pups, and the coronal sutures were analyzed at 5 weeks. The skulls were stained with alcian blue and alizarin red. The left panels are wholemount analyses of the
coronal sutures. The right panels are cross sections through the coronal sutures indicated by thewhite lines in the left panels. Representative examples are shown. (C) Table indicating
the penetrance and degree of suture fusion. Skulls were assessed using a scoring system inwhich a suture was assigned a value from 0 to 3: 0 is completely unfused; 1 is 30% fused; 2
is 60% fused; and 3 is 100% fused. Left and right coronal sutures were scored individually for each skull. For each genotype, the scoringmean SEMwas determined andwas termed the
craniosynostosis index (CI). Statistical analysis was performed by one-way analysis of variance. Cre expression alone did not affect the Twist1+/− phenotype, and therefore all of the
mice that were Twist1+/− but did not have both the CAG–CreERT2 and CG–Spry1 transgenes, and therefore did not express Spry1, were designated as being Twist1+/−. For the same
reason, all mice that were wild type for Twist1 were all considered wild type in computing the CI. The difference between Twist1+/− and Twist1+/−;CG–Spry1;CAG–CreERT2mice, with
activated Spry1 expression, was highly signiﬁcant (p=0.001). Penetrance was calculated as the percentage of animals that exhibited any coronal suture fusion.
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explants were stained with alcian blue and alizarin red to determine
the extent of suture closure. We deﬁned suture closure as when the
two parietal bones touched or overlapped at any point. BSA beads did
not induce suture closure in any cases. When FGF2-beads were placed
on the osteogenic fronts, the sutures grew together in both wild type
and Twist1+/− explants. However, when beads were placed on the mid-
suture, suture closure was only seen in the Twist1+/− calvaria (Fig. 3B).
Therefore, the expanded FGFR2 expression in Twist1+/− sutures leads to
increased FGF responsiveness.
Inhibition of FGFR rescues suture fusion in Twist1+/− mice
Since the sutures of Twist1+/− skulls had increased FGF respon-
siveness, we next addressed whether FGF signaling was required for
suture fusion in Twist1+/− mice. Unlike in humans where suture
fusion due to TWIST1 haploinsufﬁciency occurs at or before birth,
suture fusion in Twist1+/− mice is delayed, and the sutures are
relatively normal at birth and do not show signs of craniosynostosis
until 3weeks of age (Carver et al., 2002). We took advantage of this
developmental delay to try and prevent suture fusion by inhibiting
FGF signaling in the sutures after birth, when the sutures are
accessible to manipulation. To inhibit FGF signaling, we used
transgenic mice that conditionally express the receptor tyrosine
kinase inhibitor Sprouty1 (Spry1) after Cre recombinase-induced
recombination (Fig. S1). We utilized an estrogen receptor/Cre
recombinase (CreERT2) fusion protein driven by the β-actin
promoter and CMV enhancer (CAG) to enable temporal control ofFig. 5. Expression of TT leads to a similar increase in FGFR2 expression and responsivene
osteoblast differentiation, while Twist1 heterodimers (CC–TE) inhibit these. All pups were
analyzed at P7. Sections through the sagittal sutures of P7 skulls fromwild type, Twist1+/−, CC–
and FGFR2 protein expression. Arrowheads indicate the osteogenic fronts. Analysis of at leas
FGFR2 expression was limited to the osteogenic fronts in wild type sutures, while Twist1+/− a
suture. Mice expressing CC–TE had even lower FGFR2 expression thanwild type. Alkaline pho
but was signiﬁcantly enhanced in CC–TT;CAG–CreERT2 mice and almost absent in CC–TE
expression. Pregnant females were injected with tamoxifen at E15 and then at E16.5 calvaria
5 days in differentiation media with FGF2 soaked beads placed on the mid-suture. FGF beads
the explanted calvaria, which did not occur in any of the control or CC–TE-expressing explaCre recombination (Hayashi and McMahon, 2002). The activation of
the CreERT2 protein was induced by injection of tamoxifen into the
sutures of P3 mice. The extent of activation of CreERT2 was tested by
injection of tamoxifen into the sutures of R26R;CAG–CreERT2 mice,
which express the LacZ gene following Cre recombination (Jiang et
al., 2002). Analysis of β-galactosidase expression in the coronal
sutures 3 days after injection indicated that there was efﬁcient
recombination throughout the suture after a single injection of
tamoxifen at P3 (Fig. 4A). P3 pups from a cross of Twist1+/−;CAG–
CreERT2 with CG–Spry1 mice were injected with tamoxifen, then
harvested 5 weeks after birth and analyzed for suture fusion.
Activation of Spry1 expression in Twist1+/− mice resulted in an
almost complete inhibition of suture fusion (Fig. 4B). The percentage
of mice showing any coronal suture fusion decreased from 81.8% of
all mice with a Twist1+/− genotype without Spry1 expression to 6.06%
of Twist1+/−;CG–Spry1;CAG–CreERT2 mice. To determine the degree to
which craniosynostosis was rescued on the different genetic back-
grounds, we used a craniosynostosis index (CI) (Connerney et al.,
2006). Left and right coronal sutures were assessed individually and
assigned a number between 0 (completely unfused) to 3 (completely
fused). The CI given in Fig. 4C indicates the average degree of
craniosynostosis for a single coronal suture. None of the mice that
were wild type for Twist1 showed any signs of suture fusion, and
therefore were combined to compute the CI of wild type mice. The
expression of Spry1 in the sutures of Twist1+/− mice signiﬁcantly
inhibited the degree of suture fusion, decreasing the CI from 1.2 in
Twist1+/− mice to 0.12 in Twist1+/−;CG–Spry1;CAG–CreERT2 mice. Mice
expressing Spry1 on a wild type background were similar to wildss as Twist1+/− mice. (A) Twist1 homodimers (CC–TT) promote FGFR2 expression and
injected with tamoxifen at P3 to induce transgene expression, and the sutures were
TT;CAG–CreERT2, and CC–TE;CAG–CreERT2mice were analyzed for alkaline phosphatase
t 3 mice of each genotype was performed, and representative data is shown. Note that
nd CC–TT;CAG–CreERT2 sutures had an expansion of this expression to the middle of the
sphatase staining was slightly expanded from the osteogenic fronts in Twist1+/− sutures,
;CAG–CreERT2 mice. (B) FGF responsiveness is enhanced by TT and decreased by TE
explants of wild type, CC–TT;CAG–CreERT2, and CC–TE;CAG–CreERT2were incubated for
placed on the mid-suture of CC–TT-expressing calvaria promoted suture closure in all of
nts.
Fig. 6. Expression of TT promotes overgrowth of the calvaria bones. (A–L) Mice were treated at P3 as in Fig. 4 and were then harvested for analysis at 5 weeks of age. Skulls were
stained with alcian blue and alizarin red and analyzed by wholemount (A–E) and sectioning (F–L). The number of mice treated was wild type (n=9), CC–TE (n=19), and CC–TT (n=8).
Coronal sutures appeared patent in wild type mice (A), while Twist1+/− sutures were fused (B). TT expression resulted in varied degrees of two phenotypes: CC–TT (u) presented with
an undulate phenotype (D), and CC–TT (s) had a serrate phenotype, which appeared to be tightly closed (E). The TE–expressing sutures were patent and showed greater separation
between the bones (C). Cross-sections of coronal sutures conﬁrmed the difference between the sutures: (F) coronal sutures from wild type adult mice showed a deﬁned opening
between the parietal and frontal bones; (G) Twist1+/− coronal sutures were clearly fused and the resulting bone was thicker than wild type; (H) CC–TE;CAG–CreERT2 sutures showed
an increased mid-suture space with thinner bone ends compared towild type; (I-L) CC–TT;CAG–CreERT2 expressing sutures of both serrate (s) (I, J) and undulate (u) (K, L) phenotypes
were signiﬁcantly expanded with severely overgrown calvaria bones that resembled the thickness of the Twist1+/− calvaria. These sutures are also shown using 4× magniﬁcation
objectives to be able to view the entire sutures (J,L).
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through the coronal sutures. This demonstrated that expression of
Spry1 on all backgrounds resulted in slightly thinner calvaria bones
(Fig. 4B), indicating a requirement of FGF signaling for normal
calvaria growth. Cre expression alone had no distinguishable affect
on calvaria growth (data not shown). Therefore, inhibition of FGF
signaling can prevent craniosynostosis in Twist1+/− mice.
Twist1 dimers have opposing effects on osteoblast differentiation and
FGF responsiveness
Our previous data suggested that the balance between T/T and
T/E is altered in Twist1+/− mice and that restoration of this balance
prevents suture closure (Connerney et al., 2006). However, these
experiments did not distinguish if suture closure in these mice
occurs due to the relative increase in T/T formation, or to the
decrease in T/E dimers, or both. Twist1 has been implicated in the
inhibition of osteoblast differentiation (Bialek et al., 2004; Funato et
al., 2001; Hayashi et al., 2007; Lee et al., 1999), and we found that
this was mediated by T/E dimers (Connerney et al., 2006). However,
since T/T dimers regulate FGFR2 expression (Connerney et al., 2006),
which is expanded to the mid-suture in Twist1+/− mice (Fig. 2)
(Connerney et al., 2006; Rice et al., 2000), T/T dimers may play an
active role in promoting suture fusion. To further test this hypo-
thesis, we asked if the expression of TT forced dimers, in which the
Twist1 monomers are linked by a ﬂexible glycine-serine polylinker
(Connerney et al., 2006), in otherwise wild type sutures would result
in a similar phenotype as that due to Twist1 haploinsufﬁciency.
Conversely, we also determined if increasing the levels of TE would
inhibit osteoblast differentiation in vivo, and lead to open sutures.
We achieved this by using a conditional transgenic system similar to
the CG–Spry1 transgenic mice explained above. After Cre-induced
recombination, the CC–TT or CC–TE mice constitutively express a
“tethered” Twist1 homodimer (TT) or heterodimer (TE) construct,
respectively (Fig. S1). CC–TT and CC–TE mice were crossed with
CAG–CreERT2mice so that Cre recombination could be controlled in a
temporal manner.
To determine if increased TT or TE expressionwould affect calvaria
differentiation or FGFR2 expression, we activated CC–TT and CC–TE
transgene expression by injecting tamoxifen into the sutures of P3
pups. The sutures were then analyzed for the osteoblast differentia-
tion marker alkaline phosphatase and FGFR2 expression at P7 when
there is active calvaria growth. TE expression dramatically reduced
alkaline phosphatase expression, while TT expression may have even
enhanced calvaria differentiation, as thesemice had increased alkaline
phosphatase staining (Fig. 5A). Alkaline phosphatase staining of
Twist1+/− sutures was slightly expanded compared to wild type
sutures (see also Fig. 2). FGFR2 expression was expanded throughout
the sagittal sutures of both Twist1+/− and TT-expressing mice. TE
expression seemed to decrease FGFR2 expression, similar to what was
observed in vitro (Connerney et al., 2006). Therefore, TE expression
inhibited osteoblast differentiation and FGFR2 expression while TT
expression enhanced them.
We next asked whether the differential expression of FGFR2
would affect the FGF responsiveness of the sutures in the CC–TT and
CC–TE mice as it did in the Twist1+/− mice. Pregnant CC–TT or CC–TE
females that had been crossed with CAG–CreERT2 males were
injected with tamoxifen at E15.5 to activate transgene expression,
and embryos were then harvested and the calvaria explanted at
E16.5. Activation of either CC–TT or CC–TE had no discernable
phenotypic effect at the time of explant (data not shown). FGF2 or
BSA beads were placed in the mid-suture as in Fig. 3, and the
explants were cultured for 5 days. FGF beads placed in the mid-
suture of TT-expressing calvaria promoted suture closure in all of the
explanted calvaria, which did not occur in any of the control or TE-
expressing explants (Fig. 5B). Therefore, increased expression ofTwist1 homodimers enhanced FGFR2 expression and FGF respon-
siveness consistent with our model in Twist1+/− mice.
Twist1 homodimers promote suture overgrowth and craniosynostosis
Since TT expression enhanced suture closure in explant cultures,
we next asked if TT expression would affect the postnatal develop-
ment of the coronal sutures in otherwise wild type mice. For these
experiments, CC–TT;CAG–CreERT2 or CC–TE;CAG–CreERT2 and control
littermates were injected with tamoxifen in the sutures at P3 to acti-
vate transgene expression. The mice were then sacriﬁced at 5 weeks
of age and the skulls were analyzed for suture closure as above. In 6
of 8 CC–TT;CAG–CreERT2 mice, the coronal sutures were distinctly
different from wild type (Fig. 6A) and uninjected control sutures. In
these mice, the coronal sutures had an undulating or serrate
phenotype (Fig. 6D, E). The coronal sutures of CC–TE;CAG–CreERT2
mice were slightly more open than controls, but otherwise looked
fairly normal (Fig. 6C). Sections through the coronal sutures further
emphasized the different suture phenotypes. The coronal sutures
from wild type mice had a deﬁned opening between the parietal and
frontal bones (Fig. 6F), which was clearly absent in the Twist1+/− mice
where the parietal and frontal bones were fused, and in comparison
with the wild type, these bones appeared thicker (Fig. 6G). TE
expression resulted in a slightly more open suture than wild type,
with thinner tips of the bones (Fig. 6H). In contrast, CC–TT;CAG–
CreERT2 mice had dramatically extended sutures, with the overlap of
the parietal and frontal bones being more than 5 times that of wild
type mice. Sections through the sutures of 2 different mice with
either undulate or serrate phenotypes are shown at both 4× and 10×
magniﬁcation (Fig. 6I–L). Interestingly, while TT expression caused
overgrowth of the calvaria bones, no actual fusion between the
frontal and parietal bones was observed, perhaps indicating that
constitutive TT expression inhibits some activity that is required for
bone fusion.
Discussion
About 25% of craniosynostosis cases can be classiﬁed into one of
about 100 different craniosynostotic syndromes, with most being due
to activating mutations in the FGFR1, FGFR2, or FGFR3 genes, or
inactivating mutations in the TWIST1 gene resulting in haploinsufﬁ-
ciency (Cunningham et al., 2007; Lenton et al., 2005; Rice, 2005). The
mechanisms linking these two pathways, however, are unclear. We
previously proposed a model where Twist1 homodimers and hetero-
dimers differentially regulate cranial suture patency (Connerney et al.,
2006). TWIST1 haploinsufﬁciency results in an imbalance between
these dimers due to increased competition with Id1 proteins for
dimerization with E proteins. This results in a higher T/T to T/E ratio
throughout the sutures leading to an expansion of the osteogenic fronts
and suture closure. Our data supported this model, and importantly we
were able to show that restoration of the normal balance between T/T
and T/E, by modulating the expression of E proteins or Id1, prevented
craniosynostosis in Twist1+/−mice (Connerney et al., 2006). The datawe
present here further supports thismodel and extends it to integrate the
Twist1 dimers with the FGF and BMP pathways, which are known to
regulate cranial suture patency (Fig. 1A). We show that the expression
of T/T and T/E differentially affect the responsiveness of the sutures to
FGF, and that inhibition of FGF signaling prevents craniosynostosis in
Twist1+/− mice, creating a more dynamic model of the regulation of
cranial suture patency (Fig. 1B).
Integration of Twist1 dimer formation and activity with the FGF and BMP
pathways
In several different organisms, changes in Twist expression alter
FGF receptor expression, however it has been unclear how direct this
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data indicate that T/T homodimers increase, and T/E heterodimers
decrease FGFR2 expression. Over-expression of TT homodimers on a
wild type background resulted in a similar phenotype as Twist1
haploinsufﬁciency, giving strong support for our model that Twist1
haploinsufﬁciency leads to a high T/T to T/E ratio throughout the
sutures. This also indicates that the T/T to T/E ratio in a cell likely
determines the functional output of Twist expression. This can be
difﬁcult to quantify because it is determined by the relative ratio of
Twist to other HLH proteins in a cell. Because there are 2 vertebrate
Twist proteins, Twist1 and Twist2 (also known as Dermo1), 4 Id
proteins and 4 E proteins, measurements can be complex. Further-
more, other bHLH proteins compete with Twist1 for dimerization
with E proteins (Spicer et al., 1996), and Twist1 can dimerize with
some other bHLH proteins such as the Hand proteins (Firulli et al.,
2005, 2007), further increasing the complexity.
In the cranial sutures, Twist1, Id1, and E proteins are all expressed.
E2A and HEB E proteins are expressed throughout the sutures and
osteogenic fronts, as well as in the differentiating osteoblasts (Funato
et al., 2001). Twist1 is expressed in the osteogenic fronts and suture
mesenchyme, while Id1 proteins are restricted to the osteogenic
fronts (Connerney et al., 2006; Johnson et al., 2000; Rice et al., 2000).
Because we previously found that Twist1 and Id1 compete for
dimerization with E proteins, and the relative level of Twist1 to Id1
determines the T/T to T/E ratio within a cell (Connerney et al., 2006),
we proposed that these expression patterns within the sutures would
result in primarily T/T dimers forming in the osteogenic fronts where
Twist1 and Id1 are co-expressed, and a predominance of T/E dimers
in the mid-sutures where only Twist1 is expressed. This was
supported by the expression patterns of genes that are differentially
regulated by T/T and T/E dimers (Connerney et al., 2006). The
expression domains of Twist1 and Id1 are largely regulated by FGF
and BMP signaling, which integrate with TGFβ to regulate suture
patency (Cunningham et al., 2007; Lenton et al., 2005; Rice, 2005).
Twist1 expression is at least in part regulated by FGF signaling,
while Id1 expression is induced by BMP signaling (Isaac et al., 2000;
Rice et al., 2000). Conversely, Twist1 dimers differentially affect the
response of cells to FGF and BMP, and may affect TGFβ-responsive-
ness as well. Our data demonstrate that T/T and T/E dimers have
opposing effects on the expression of FGFR2, resulting in a
differential response of cells in the osteogenic fronts and mid-suture
to FGF. We also show that BMP signaling is restricted to the
osteogenic fronts of wild type sutures, even though BMP4 is
expressed throughout the sutures (Warren et al., 2003). This
restriction may be due to T/E dimers in the mid-suture, since they
have been shown to inhibit BMP signaling (Hayashi et al., 2007). The
BMP inhibitor noggin is also expressed in the mid-suture mesench-
yme (Warren et al., 2003), and may cooperate with the T/E dimers to
restrict BMP signaling to the osteogenic fronts, however we found
noggin expression to be quite low in the sutures. The role of TGFβ
in regulating suture patency is complex, but may also be affected by
Twist1 dimer formation. TGFβ2 promotes suture closure, while
TGFβ3 inhibits closure (Opperman et al., 1999). Interestingly, we
found that T/E heterodimers regulate the expression of TSP1 in the
mid-suture mesenchyme (Connerney et al., 2006). One of the
functions of TSP1 is to activate latent TGFβ (Annes et al., 2003).
The mechanism of TGFβ activation in the cranial sutures has not been
studied, and perhaps TSP1 plays a role in this.
Our model (Fig. 1) indicates how relatively small changes in the
dosage of Twist1 can dramatically alter the regulation of suture pa-
tency by affecting FGF, BMP, and potentially TGFβ signaling, and
these pathways in turn can affect the balance between T/T and T/E by
modulating the expression of Twist1 and Id1. Because Twist1 and Id1
compete for dimerization with E proteins (Connerney et al., 2006),
we hypothesize that the decrease in Twist1 expression due to Twist1
haploinsufﬁciency results in a higher T/T to T/E ratio extendingbeyond the osteogenic fronts due to Id1 levels out-competing Twist1
for dimerization with E proteins. This results in an expansion of
FGFR2 expression and an increase in FGF responsiveness beyond the
osteogenic fronts. The decrease in T/E formation, perhaps combined
with a decrease in noggin expression due to the increased FGF
signaling (Warren et al., 2003), would lead to an increase in BMP
signaling. The BMP signaling would increase Id1 expression, further
enhancing T/T formation. This positive feedback loop would continue
to promote the expansion of FGF and BMP signaling throughout the
sutures, resulting in their premature closure and craniosynostosis.
Our data support this model, showing increased FGF and BMP
signaling, and Id1 expression throughout the sutures of Twist1+/−
mice.
T/T and T/E dimers differentially regulate osteoblast differentiation
Twist1 inhibits osteoblast differentiation (Bialek et al., 2004;
Funato et al., 2001; Hayashi et al., 2007; Lee et al., 1999), but our
data indicate that this activity is restricted to T/E dimers because
Twist1 required heterodimerization with E proteins to inhibit the
differentiation of primary calvaria osteoblasts (Connerney et al.,
2006). Furthermore, T/E heterodimerization was shown to be
required to inhibit BMP-induced osteoblast differentiation (Hayashi
et al., 2007). Interestingly, this inhibition was relieved by the
expression of Id1, which would be expected to promote T/T
formation (Hayashi et al., 2007). In the present study, we found
that TT expression resulted in increased alkaline phosphatase
activity and dramatic overgrowth of the calvaria bones, which
suggest that T/T dimers may even promote osteoblast differentia-
tion. TE expression resulted in signiﬁcant inhibition of alkaline
phosphatase expression in the osteogenic fronts at P7, however at
5 weeks the sutures were only slightly more open than controls
with thinner tips of the bones. This suggests that osteoblast
differentiation is only delayed by T/E dimers, as compared to
myoblast differentiation, which is completely inhibited due to T/E
expression (Hamamori et al., 1997; Hebrok et al., 1994; Leshem et al.,
2000; Spicer et al., 1996). A lack of severe inhibition by TE dimers
was also recently observed by expression of TE forced dimers during
limb development, where the bones ended up being slightly shorter,
but there was clearly substantial osteogenesis occurring (Firulli et
al., 2007). We have also observed that the initial inhibition of
osteoblast differentiation by Twist1 in vitro is much less signiﬁcant
as differentiation proceeds, which is not true for the inhibition of
myogenesis by Twist1 (data not shown). We believe that this,
coupled with different culture conditions affecting which Twist1
dimer is favored, can lead to confusing results. For instance, three
studies on the differentiation properties of TWIST1 haploinsufﬁcient
osteoblasts came to three different conclusions about whether the
cells differentiated faster, slower, or the same as controls (Guenou et
al., 2005; Ratisoontorn et al., 2005; Yousﬁ et al., 2001). Since the
expression of the Id1 gene is highly regulated by culture conditions,
small changes in conﬂuency, or even the type of serum used, or
when it was added could easily affect the T/T to T/E ratio in the cells
and alter the effect on differentiation.
T/T dimers play an active role in promoting craniosynostosis
Expression of TT dimers in the sutures resulted in a phenotype that
closely resembled that of Twist1 haploinsufﬁciency. The expression of
TT caused a similar expansion of FGFR2 expression and increased FGF
responsiveness of the sutures. Furthermore, the TT over-expressing
sutures had a serrate and undulate phenotype sometimes observed in
Twist1+/− sutures. Histological analysis of calvarial bones of patients
with activating mutations of FGFR2 show that these samples have
increased alkaline phosphatase activity, accelerated ossiﬁcation, and
increased thickness of the calvaria bones compared with normal
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the coronal suture in our TT over-expressing transgenic mice also had
increased alkaline phosphatase activity, accelerated ossiﬁcation, and
increased thickness of the calvarial bone. These data strongly support
an active role for T/T dimers in promoting craniosynostosis in TWIST1
haploinsufﬁciency.
Our data indicate that TTexpression affects the osteogenic fronts as
well as the mid-suture mesenchyme, and these changes closely reﬂect
the changes seen in the sutures of Twist1+/− mice. While the sutures
were not signiﬁcantly morphologically different than wild type
sutures up to P7, there was increased alkaline phosphatase in the
osteogenic fronts and changes in gene expression and increased FGF
and BMP signaling throughout the sutures. These changes in gene
expression signiﬁcantly altered the response of the mid-suture cells to
FGF and promoted suture closure in our explant studies. Our
experiments cannot distinguish whether TT expression in the osteo-
genic fronts, mid-suture mesenchyme, or both was important for
promoting the calvaria outgrowth seen at 5 weeks, however our data
from the calvaria explants suggest that it may be due to an effect on
both cell populations. A recent study using cell transplants from
different regions of the sagittal suture demonstrated that in wild type
mice cells just outside of the osteogenic fronts are able to participate
in the formation of the calvaria bones, however the cells in the mid-
suture are not (Lana-Elola et al., 2007). It would be interesting to do
similar assays with Twist1+/− and TT-expressing sutures to see if the
fate, or potency of these mid-suture cells has changed.
Interestingly, TT expression resulted in overgrowth of the calvaria
bones, but no overt fusion was observed. The mechanisms regulating
fusion of the calvaria bones are really unknown. The transgenic system
that we used results in constitutive expression of TT, or TE, throughout
the suture and osteogenic fronts after recombination. Twist1 is normally
expressed in these tissues, but its expression declines as the cells
differentiate. There is the possibility that maintenance of TT expression
in these cellsmay block someaspect that is required for the twobones to
adhere and fusewith each other. Alternatively, actual fusionmay require
an absence of T/E dimers,whichmay still be present in the sutures of the
TT-expressing mice, but not in Twist1+/− mice. Increased proliferation
and differentiation have beenproposed to be themechanisms that drive
craniosynostosis due to activated FGFR2 mutations (Ornitz and Marie,
2002), however our data indicate that simply overgrowth of the calvaria
is not sufﬁcient to cause suture fusion.
In conclusion, we propose that the balance between T/T and T/E
dimers plays a central role in integrating FGF, BMP, and perhaps TGFβ
signaling to regulate cranial suture growth and patency. Clearly, there
are other factors that need to be incorporated into this model, but
this type of complex feedback regulation can help explain why there
is such phenotypic variability in many craniosynostosis syndromes.
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